Meet the team

Who We Are

New Equilibrium brings together interdisciplinary experts with the shared goal of drugging intrinsically disordered proteins.

Leadership Team

Virginia Burger, Ph.D.
Co–founder and CEO

Soumya Ray, Ph.D.
Interim CTO

Peter Tompa, Ph.D.
Co–founder and Chair of SAB

Discovery Team

Charles DeLisle, Ph.D.
Senior Scientist, Biophysics

Hsiao-Yun Chen, Ph.D.
Senior Scientist, Biochemistry & Cell Biology

Platform Development Team

Lars Bratholm, Ph.D.
Principal Scientist, Machine Learning

Tao Jiang, Ph.D.
Senior Scientist, Computational Chemistry

Acadia Connor, B.A.
HPC Program Manager and Research Associate II, Computational Chemistry

Bentley Wingert, Ph.D.
Advanced Analytics Data Science Intern

Business Development Team

Hang Cao, B.F.A.
Communications Manager and DEI Coordinator

Austin Alexander, B.S.
Operations Manager

Scientific Advisory Board

Lila M. Gierasch, Ph.D.
 Professor, Chemistry & Biochemistry and Molecular Biology, UMass Amherst

AJ Milici, Ph.D.
President, Milici Consulting LLC

Emir Roach, M.D.
Principal, Biopharma, Boston Consulting Group

Jianhan Chen, Ph.D.
 Professor, Chemistry & Biochemistry and Molecular Biology, UMass Amherst

Olexandr Isayev, Ph.D.
Professor, Department of Chemistry, Carnegie Mellon University

Sally Wang Liang, J.D./M.P.H.
VP of Business Development, Head of Global Business Unit, PepLib

VK Gadi, M.D. PH.D.
Professor and Director, Medical Oncology, U of Illinois at Chicago

Keith Dunker, Ph.D.
 Professor Emeritus of Biochemistry and Molecular Biology, Indiana University

Zsuzsanna Dosztányi, Ph.D.
Professor, Biochemistry, Eötvös Loránd University